DR. ZELIG ApS: Financial statements 2023
CVR: 29421323
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
DR. ZELIG ApS (CVR 29421323) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -171 and a net result of DKK 1,549,047 compared with DKK -2,042,628 the year before. Equity in the 2023 report amounted to DKK 43,803,636. The solvency ratio was 100%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -171
- Profit/Loss
- DKK 1,549,047
- Equity
- DKK 43,803,636
- Total Assets
- DKK 43,803,636
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -171 | 1.5 mio. | 43.8 mio. | 1 |
| 2022 | - | -22 t. | -2 mio. | 43.5 mio. | 1 |
| 2021 | - | 155 t. | 36 mio. | 47 mio. | 1 |
| 2020 | - | -120 t. | -241 t. | 12.5 mio. | 1 |
| 2019 | - | 0 | -5.5 mio. | 12.9 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DR. ZELIG ApS has published its annual report for 2022. Gross profit came to DKK -21,807, and the net result was DKK -2,042,628.
About DR. ZELIG ApS
DR. ZELIG ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Edvard Wulff. The company is owned by Morten Edvard Wulff. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 5,881,022 compared with DKK 7,625,711 the year before. Equity in the 2025 report amounted to DKK 55,061,769.